Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,767 | 9,055 | 11,997 | 15,640 | 17,918 |
| Receivables | 51 | 139 | 119 | 87 | 64 |
| Other current assets | 25 | 25 | 0 | 0 | 0 |
| TOTAL | $6,905 | $9,287 | $12,228 | $15,860 | $18,086 |
| Non-Current Assets | |||||
| Intangibles | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $2 | $2 | $2 | $2 | $2 |
| Total Assets | $6,907 | $9,288 | $12,230 | $15,862 | $18,088 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 302 | 792 | 389 | 505 | 263 |
| TOTAL | $302 | $792 | $389 | $505 | $263 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $302 | $792 | $389 | $505 | $263 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 2,367 | N/A |
| Common Shares | 21,292 | 21,451 | 21,566 | 21,434 | 22,024 |
| Retained earnings | -16,613 | -14,651 | -11,163 | -7,290 | -5,164 |
| Other shareholders' equity | 1,926 | 1,696 | 1,438 | 1,212 | 965 |
| TOTAL | $6,605 | $8,496 | $11,841 | $15,357 | $17,825 |
| Total Liabilities And Equity | $6,907 | $9,289 | $12,230 | $15,862 | $18,088 |